radiolabeled somatostatin analogs (Mallinckrodt)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameradiolabeled somatostatin analogs (Mallinckrodt)
Drug Alias Name64Cu-CB-TE2A-Y3-TATECopper-64-CB-TE2A-Y3-TATECopper-64-CB-TE2A-[3-Tyr]-octreotateTETA-[Tyr3]-octreotate-[64Cu]64Cu-TETA-Y3-TATE +[9] 
ClassificationBiologics > Protein drugs > Recombinant polypeptideRadiation-emitting products
Mechanisms of ActionSomatostatin receptor agonists
TargetsSomatostatin receptor
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMallinckrodt Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMallinckrodt Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A